|
|
||||||||||
Clinical Pharmacist, Department of Pharmacy, University Hospital Doce de Octubre, Madrid, Spain
Clinical Pharmacist, Department of Pharmacy, University Hospital Doce de Octubre
Family Physician, Research Unit, 11th Health Area, Madrid
Clinical Pharmacist, Department of Pharmacy, University Hospital Doce de Octubre
HIV Clinical Specialist, HIV Unit, Department of Internal Medicine, University Hospital Doce de Octubre
HIV Clinical Specialist, HIV Unit, Department of Internal Medicine, University Hospital Doce de Octubre
Reprints: Ismael Escobar PharmD, Department of Pharmacy, University Hospital Doce de Octubre, Crta. Andalucía, Km 5,400. 28047 Madrid, Spain, FAX 34-91 3908005, E-mail simonescobar{at}airtel.net
OBJECTIVE: To determine the clinical and demographic variables related to adherence to highly active antiretroviral therapy (HAART) in patients treated in our hospital and identify the characteristics of nonadherent patients.
METHODS: Outpatients receiving treatment with HAART (n =
283) were asked about variables related to adherence and to complete the APGAR
(family support), State-Trait Anxiety questionnaire (STAI) (emotional
situation), and IAS (social support) questionnaires. Patients were classified
in 2 groups depending on whether adherence was
95% or <95%. Adherence
was defined as the percentage of dosage forms prescribed that were obtained by
the patient at the hospital pharmacy. A multivariate analysis was created to
analyze how each significant variable affected adherence.
RESULTS: Our data showed significant nonadherence for patients with the following factors: low level of education, unemployed, emotional situation, and abuse of substances including intravenous drugs. All significant variables were included in a logistic regression model to optimize the results. This model considered 4 variables: age (95% CI 0.89 to 0.99), number of antiretroviral drugs (95% CI 1.05 to 2.11), STAI Anxiety/Trait test (95% CI 2.02 to 6.02), and abuse of drugs (95% CI 1.20 to 3.95).
CONCLUSIONS: We recommended special intervention to reinforce adherence for younger patients, patients taking a high number of antiretroviral drugs, those who have a history of intravenous drug use, and those with high anxiety status.
Key Words: adherence, antiretroviral treatment, adherence
This article has been cited by other articles:
![]() |
M. A. Jhaveri, S. R. Browning, H. Bush, A. Thornton, and R. N. Greenberg Comparison of 3-Drug Versus 4-Drug and PI Versus Non-PI Combinations as Initial HAART: Experience From 1998 to 2007 J Int Assoc Physicians AIDS Care (Chic Ill), September 1, 2009; 8(5): 299 - 307. [Abstract] [PDF] |
||||
![]() |
S. Corvaisier, B. Charpiat, C. Mounier, M. Wallon, G. Leboucher, M. Al Kurdi, J.-F. Chaulet, and F. Peyron Population Pharmacokinetics of Pyrimethamine and Sulfadoxine in Children Treated for Congenital Toxoplasmosis Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3794 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ngo and S. S Sansgiry Comment: factors affecting patient adherence to highly active antiretroviral therapy Ann. Pharmacother., March 1, 2004; 38(3): 511 - 511. [Full Text] [PDF] |
||||